vTv Therapeutics Stock (NASDAQ: VTVT) stock price, news, charts, stock research, profile.
You can purchase shares of vTv Therapeutics (NASDAQ:VTVT) through any online brokerage.
Other companies in vTv Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Serina Therapeutics (AMEX:SER), CytomX Therapeutics (NASDAQ:CTMX), Estrella Immunopharma (NASDAQ:ESLA) and Gain Therapeutics (NASDAQ:GANX).
vTv Therapeutics has a consensus price target of $14.33.
The stock price for vTv Therapeutics (NASDAQ: VTVT) is $20.6 last updated February 21, 2025 at 6:37 AM EST.
There are no upcoming dividends for vTv Therapeutics.
vTv Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for vTv Therapeutics.
vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.